|
|
|
| |
|
|
| |
The latest immunology news from News Medical |
|
|
|
 | | |
 Engineering the Next Generation of Vaccines
Vaccine innovation is advancing through recombinant technologies, mRNA platforms, and AI—enhancing precision, speed, and adaptability. Sino Biological leads this transformation by providing high-quality recombinant viral proteins, virus antibodies, and end-to-end solutions across all stages of vaccine development, from early discovery to clinical production.
| |
|
|
|
|
| | |  An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. | | | | |  The world's first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young Asian elephants – is safe and triggers a strong virus-fighting immune response, according to an international team led by the University of Surrey, in collaboration with Chester Zoo and the Animal and Plant Health Agency. | | | | |  UCLA researchers have uncovered a link between "morning sickness" symptoms and the body's natural, but complex, inflammatory response to biological and bodily changes during pregnancy. | | | | |  The World Health Organization (WHO) today announced its recommendations for the viral composition of influenza vaccines for use in the 2026 influenza season in the southern hemisphere. | | | | |  Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa. | | | | |  A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Cincinnati Children's. | | | | |  A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. | |
|
|
|
 | | | How would you rate today's newsletter?
| |
|
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
